Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 33% ± 10% | |
brain | 17 studies | 40% ± 20% | |
lung | 14 studies | 26% ± 13% | |
kidney | 9 studies | 21% ± 4% | |
eye | 9 studies | 35% ± 12% | |
intestine | 7 studies | 27% ± 10% | |
heart | 5 studies | 29% ± 6% | |
bone marrow | 4 studies | 35% ± 12% | |
adipose | 4 studies | 42% ± 15% | |
uterus | 3 studies | 28% ± 10% | |
liver | 3 studies | 32% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 12550.94 | 2642 / 2642 | 100% | 134.06 | 704 / 705 |
ovary | 100% | 7050.63 | 180 / 180 | 100% | 41.38 | 428 / 430 |
intestine | 100% | 7695.61 | 964 / 966 | 100% | 77.14 | 525 / 527 |
thymus | 100% | 12465.60 | 653 / 653 | 99% | 66.45 | 599 / 605 |
stomach | 100% | 5497.51 | 359 / 359 | 98% | 81.23 | 281 / 286 |
esophagus | 100% | 5994.25 | 1441 / 1445 | 97% | 67.29 | 178 / 183 |
kidney | 100% | 6848.82 | 89 / 89 | 95% | 56.30 | 856 / 901 |
lung | 99% | 6680.01 | 574 / 578 | 95% | 53.02 | 1092 / 1155 |
pancreas | 96% | 4198.61 | 314 / 328 | 97% | 58.99 | 173 / 178 |
bladder | 100% | 6244.67 | 21 / 21 | 92% | 43.81 | 462 / 504 |
uterus | 99% | 4508.29 | 168 / 170 | 92% | 41.35 | 422 / 459 |
breast | 100% | 9342.31 | 459 / 459 | 88% | 34.94 | 981 / 1118 |
skin | 100% | 8257.52 | 1807 / 1809 | 84% | 37.06 | 397 / 472 |
prostate | 100% | 5582.82 | 244 / 245 | 82% | 27.88 | 414 / 502 |
adrenal gland | 90% | 2879.50 | 231 / 258 | 81% | 29.10 | 186 / 230 |
spleen | 100% | 5258.01 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.92 | 1 / 1 |
adipose | 100% | 9461.15 | 1202 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 6044.43 | 841 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 5761.88 | 1298 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 50.24 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 93% | 31.69 | 27 / 29 |
peripheral blood | 87% | 5022.10 | 804 / 929 | 0% | 0 | 0 / 0 |
liver | 19% | 411.12 | 44 / 226 | 45% | 12.09 | 182 / 406 |
eye | 0% | 0 | 0 / 0 | 51% | 12.04 | 41 / 80 |
muscle | 17% | 380.37 | 136 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051495 | Biological process | positive regulation of cytoskeleton organization |
GO_0045907 | Biological process | positive regulation of vasoconstriction |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0007010 | Biological process | cytoskeleton organization |
GO_0051016 | Biological process | barbed-end actin filament capping |
GO_0005911 | Cellular component | cell-cell junction |
GO_0005903 | Cellular component | brush border |
GO_0000794 | Cellular component | condensed nuclear chromosome |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005938 | Cellular component | cell cortex |
GO_0005886 | Cellular component | plasma membrane |
GO_0014069 | Cellular component | postsynaptic density |
GO_0016020 | Cellular component | membrane |
GO_0005080 | Molecular function | protein kinase C binding |
GO_0005200 | Molecular function | structural constituent of cytoskeleton |
GO_0051015 | Molecular function | actin filament binding |
GO_0005516 | Molecular function | calmodulin binding |
Gene name | ADD3 |
Protein name | Adducin 3 (Gamma), isoform CRA_a (cDNA FLJ77558, highly similar to Homo sapiens adducin 3 (gamma) (ADD3), transcript variant 1, mRNA) Gamma-adducin (Adducin-like protein 70) |
Synonyms | ADDL hCG_1789399 |
Description | FUNCTION: Membrane-cytoskeleton-associated protein that promotes the assembly of the spectrin-actin network. Plays a role in actin filament capping . Binds to calmodulin (Probable). Involved in myogenic reactivity of the renal afferent arteriole (Af-art), renal interlobular arteries and middle cerebral artery (MCA) to increased perfusion pressure. Involved in regulation of potassium channels in the vascular smooth muscle cells (VSMCs) of the Af-art and MCA ex vivo. Involved in regulation of glomerular capillary pressure, glomerular filtration rate (GFR) and glomerular nephrin expression in response to hypertension. Involved in renal blood flow (RBF) autoregulation. Plays a role in podocyte structure and function. Regulates globular monomer actin (G-actin) and filamentous polymer actin (F-actin) ratios in the primary podocytes affecting actin cytoskeleton organization. Regulates expression of synaptopodin, RhoA, Rac1 and CDC42 in the renal cortex and the primary podocytes. Regulates expression of nephrin in the glomeruli and in the primary podocytes, expression of nephrin and podocinin in the renal cortex, and expression of focal adhesion proteins integrin alpha-3 and integrin beta-1 in the glomeruli. Involved in cell migration and cell adhesion of podocytes, and in podocyte foot process effacement. Regulates expression of profibrotics markers MMP2, MMP9, TGF beta-1, tubular tight junction protein E-cadherin, and mesenchymal markers vimentin and alpha-SMA (By similarity). Promotes the growth of neurites (By similarity). . |
Accessions | Q5VU08 ENST00000356080.9 [Q9UEY8-1] ENST00000277900.12 [Q9UEY8-2] ENST00000360162.7 [Q9UEY8-2] Q9UEY8 |